116 related articles for article (PubMed ID: 35809792)
21. Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide.
Mitterberger M; Neuwirt H; Cavarretta IT; Hobisch A; Culig Z
Prostate; 2007 Aug; 67(11):1194-201. PubMed ID: 17520660
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP.
Jeon KI; Rih JK; Kim HJ; Lee YJ; Cho CH; Goldberg ID; Rosen EM; Bae I
FEBS Lett; 2003 Jun; 544(1-3):246-51. PubMed ID: 12782325
[TBL] [Abstract][Full Text] [Related]
23. Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.
Ko H; Jeong MH; Jeon H; Sung GJ; So Y; Kim I; Son J; Lee SW; Yoon HG; Choi KC
Oncotarget; 2015 Apr; 6(12):9970-84. PubMed ID: 25991668
[TBL] [Abstract][Full Text] [Related]
24. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
[TBL] [Abstract][Full Text] [Related]
26. Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells.
Deeb D; Xu YX; Jiang H; Gao X; Janakiraman N; Chapman RA; Gautam SC
Mol Cancer Ther; 2003 Jan; 2(1):95-103. PubMed ID: 12533677
[TBL] [Abstract][Full Text] [Related]
27. Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis.
Yamaguchi K; Uzzo RG; Pimkina J; Makhov P; Golovine K; Crispen P; Kolenko VM
Oncogene; 2005 Sep; 24(38):5868-77. PubMed ID: 15897871
[TBL] [Abstract][Full Text] [Related]
28. Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells.
Taylor DJ; Parsons CE; Han H; Jayaraman A; Rege K
BMC Cancer; 2011 Nov; 11():470. PubMed ID: 22044796
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
30. eNOS protects prostate cancer cells from TRAIL-induced apoptosis.
Tong X; Li H
Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122
[TBL] [Abstract][Full Text] [Related]
31. hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.
Li H; Wang X; Li N; Qiu J; Zhang Y; Cao X
J Biol Chem; 2007 Feb; 282(7):4943-4950. PubMed ID: 17178731
[TBL] [Abstract][Full Text] [Related]
32. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
[TBL] [Abstract][Full Text] [Related]
33. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
[TBL] [Abstract][Full Text] [Related]
34. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J
Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474
[TBL] [Abstract][Full Text] [Related]
35. Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL).
Eid MA; Lewis RW; Kumar MV
Mol Cancer Ther; 2002 Aug; 1(10):831-40. PubMed ID: 12492116
[TBL] [Abstract][Full Text] [Related]
36. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways.
Chang YM; Shih YL; Chen CP; Liu KL; Lee MH; Lee MZ; Hou HT; Huang HC; Lu HF; Peng SF; Chen KW; Yeh MY; Chung JG
Environ Toxicol; 2019 Dec; 34(12):1329-1339. PubMed ID: 31436044
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells.
Munshi A; McDonnell TJ; Meyn RE
Cancer Chemother Pharmacol; 2002 Jul; 50(1):46-52. PubMed ID: 12111111
[TBL] [Abstract][Full Text] [Related]
38. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
39. Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists.
Barua S; Linton RS; Gamboa J; Banerjee I; Yarmush ML; Rege K
Cancer Lett; 2010 Jul; 293(2):240-53. PubMed ID: 20347216
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
